Genen­tech opens new $250M bi­o­log­ics man­u­fac­tur­ing site in South San Fran­cis­co

While Genen­tech and Roche have been on the hunt for can­cer ther­a­pies, they’ve al­so been in­vest­ing in new con­struc­tion.

The com­pa­ny an­nounced on Tues­day that it has opened the doors to its new $250 mil­lion man­u­fac­tur­ing site for small-batch bi­o­log­ics in South San Fran­cis­co.

The site, called the “Clin­i­cal Sup­ply Cen­ter,” will even­tu­al­ly make Genen­tech’s ex­per­i­men­tal drugs, the Roche sub­sidiary tells End­points News via email.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN